{
    "abstract": "Introduction: Rotavirus disease in Mongolia is estimated to cause more than 50 deaths yearly and many more cases and hospitalizations. Mongolia must self-finance new vaccines and does not automatically access Gavi prices for vaccines. Given the country's limited resources for health, it is critical to assess potential new vaccine programs. This evaluation estimates the impact, cost-effectiveness, and budget implications associated with a nationwide rotavirus vaccine introduction targeting infants as part of the national immunization program in Mongolia, in order to inform decision-making around introduction. Methods: The analysis examines the use of the two-dose vaccine ROTARIX\u00ae, and three-dose vaccines ROTAVAC\u00ae and RotaTeq\u00ae compared to no vaccination from the government and the societal perspective. We use a modelling approach informed by local data and published literature to analyze the impact and cost-effectiveness of rotavirus vaccination over a ten-year time period starting in 2019, using a 3% discount rate. Our main outcome measure is the incremental cost-effectiveness ratio (ICER) expressed as US dollar per DALY averted. We assessed uncertainty around a series of parameters through univariate sensitivity analysis. Results: Rotavirus vaccination in Mongolia could avert more than 95,000 rotavirus cases and 271 deaths, over 10 years. Averted visits and hospitalizations represent US$2.4 million in health care costs saved by the government. The vaccination program cost ranges from $6 to $11 million depending on vaccine choice. From the governmental perspective, ICER ranged from $412 to $1050 and from $77 to $715 when considering the societal perspective. Sensitivity analysis highlights vaccine price as the main driver of uncertainty. Conclusion: Introduction of rotavirus vaccination is likely to be highly cost-effective in Mongolia, with ICERs estimated at only a fraction of Mongolia's per capita GDP. From an economic standpoint, ROTAVAC\u00ae is the least costly and most cost-effective product choice.",
    "bib_entries": {
        "b0005": {
            "authors": [
                {
                    "first": "Jacqueline E.",
                    "initial": "J.E.",
                    "last": "Tate"
                },
                {
                    "first": "Anthony H.",
                    "initial": "A.H.",
                    "last": "Burton"
                },
                {
                    "first": "Cynthia",
                    "initial": "C.",
                    "last": "Boschi-Pinto"
                },
                {
                    "first": "Umesh D.",
                    "initial": "U.D.",
                    "last": "Parashar"
                },
                {
                    "first": "Mary",
                    "initial": "M.",
                    "last": "Agocs"
                },
                {
                    "first": "Fatima",
                    "initial": "F.",
                    "last": "Serhan"
                },
                {
                    "first": "Lucia",
                    "initial": "L.",
                    "last": "De Oliveira"
                },
                {
                    "first": "Jason M.",
                    "initial": "J.M.",
                    "last": "Mwenda"
                },
                {
                    "first": "Richard",
                    "initial": "R.",
                    "last": "Mihigo"
                },
                {
                    "first": "Pushpa",
                    "initial": "P.",
                    "last": "Ranjan Wijesinghe"
                },
                {
                    "first": "Nihal",
                    "initial": "N.",
                    "last": "Abeysinghe"
                },
                {
                    "first": "Kimberley",
                    "initial": "K.",
                    "last": "Fox"
                },
                {
                    "first": "Fem",
                    "initial": "F.",
                    "last": "Paladin"
                },
                {
                    "first": null,
                    "initial": null,
                    "last": null
                }
            ],
            "doi": "10.1093/cid/civ1013",
            "firstpage": "S96",
            "issn": "10584838",
            "lastpage": "S105",
            "pmid": "27059362",
            "pub_year": 2016,
            "title": "Global, Regional, and National Estimates of Rotavirus Mortality in Children <5 Years of Age, 2000-2013",
            "volume": "62"
        },
        "b0010": null,
        "b0015": null,
        "b0020": null,
        "b0025": null,
        "b0030": null,
        "b0035": null,
        "b0040": null,
        "b0045": null,
        "b0050": null,
        "b0055": null,
        "b0060": {
            "authors": [
                {
                    "first": "Nita",
                    "initial": "N.",
                    "last": "Bhandari"
                },
                {
                    "first": "Temsunaro",
                    "initial": "T.",
                    "last": "Rongsen-Chandola"
                },
                {
                    "first": "Ashish",
                    "initial": "A.",
                    "last": "Bavdekar"
                },
                {
                    "first": "Jacob",
                    "initial": "J.",
                    "last": "John"
                },
                {
                    "first": "Kalpana",
                    "initial": "K.",
                    "last": "Antony"
                },
                {
                    "first": "Sunita",
                    "initial": "S.",
                    "last": "Taneja"
                },
                {
                    "first": "Nidhi",
                    "initial": "N.",
                    "last": "Goyal"
                },
                {
                    "first": "Anand",
                    "initial": "A.",
                    "last": "Kawade"
                },
                {
                    "first": "Gagandeep",
                    "initial": "G.",
                    "last": "Kang"
                },
                {
                    "first": "Sudeep Singh",
                    "initial": "S.S.",
                    "last": "Rathore"
                },
                {
                    "first": "Sanjay",
                    "initial": "S.",
                    "last": "Juvekar"
                },
                {
                    "first": "Jayaprakash",
                    "initial": "J.",
                    "last": "Muliyil"
                },
                {
                    "first": "Alok",
                    "initial": "A.",
                    "last": "Arya"
                },
                {
                    "first": "Hanif",
                    "initial": "H.",
                    "last": "Shaikh"
                },
                {
                    "first": "Vinod",
                    "initial": "V.",
                    "last": "Abraham"
                },
                {
                    "first": "Sudhanshu",
                    "initial": "S.",
                    "last": "Vrati"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Proschan"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Kohberger"
                },
                {
                    "first": "Georges",
                    "initial": "G.",
                    "last": "Thiry"
                },
                {
                    "first": "Roger",
                    "initial": "R.",
                    "last": "Glass"
                },
                {
                    "first": "Harry B.",
                    "initial": "H.B.",
                    "last": "Greenberg"
                },
                {
                    "first": "George",
                    "initial": "G.",
                    "last": "Curlin"
                },
                {
                    "first": "Krishna",
                    "initial": "K.",
                    "last": "Mohan"
                },
                {
                    "first": "G. V.J.A.",
                    "initial": "G.V.J.A.",
                    "last": "Harshavardhan"
                },
                {
                    "first": "Sai",
                    "initial": "S.",
                    "last": "Prasad"
                },
                {
                    "first": "T. S.",
                    "initial": "T.S.",
                    "last": "Rao"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Boslego"
                },
                {
                    "first": "Maharaj Kishan",
                    "initial": "M.K.",
                    "last": "Bhan"
                }
            ],
            "doi": "10.1016/S0140-6736(13)62630-6",
            "firstpage": "2136",
            "issn": "01406736",
            "lastpage": "2143",
            "pmid": "24629994",
            "pub_year": 2014,
            "title": "Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: A randomised, double-blind, placebo-controlled trial",
            "volume": "383"
        },
        "b0065": null,
        "b0070": null,
        "b0075": null,
        "b0080": null,
        "b0085": {
            "authors": [
                {
                    "first": "Jon Kim",
                    "initial": "J.K.",
                    "last": "Andrus"
                },
                {
                    "first": "Cristiana M.",
                    "initial": "C.M.",
                    "last": "Toscano"
                },
                {
                    "first": "Merle",
                    "initial": "M.",
                    "last": "Lewis"
                },
                {
                    "first": "Lucia",
                    "initial": "L.",
                    "last": "Oliveiria"
                },
                {
                    "first": "Alba Maria",
                    "initial": "A.M.",
                    "last": "Ropero"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "D\u00e1vila"
                },
                {
                    "first": "John W.",
                    "initial": "J.W.",
                    "last": "Fitzsimmons"
                }
            ],
            "firstpage": "811",
            "issn": "00333549",
            "lastpage": "816",
            "pmid": "18051674",
            "pub_year": 2007,
            "title": "A model for enhancing evidence-based capacity to make informed policy decisions on the introduction of new vaccines in the Americas: PAHO's ProVac initiative",
            "volume": "122"
        },
        "b0090": {
            "authors": [
                {
                    "first": "Andrew",
                    "initial": "A.",
                    "last": "Clark"
                },
                {
                    "first": "Barbara",
                    "initial": "B.",
                    "last": "Jauregui"
                },
                {
                    "first": "Ulla",
                    "initial": "U.",
                    "last": "Griffiths"
                },
                {
                    "first": "Cara B.",
                    "initial": "C.B.",
                    "last": "Janusz"
                },
                {
                    "first": "Brenda",
                    "initial": "B.",
                    "last": "Bola\u00f1os-Sierra"
                },
                {
                    "first": "Rana",
                    "initial": "R.",
                    "last": "Hajjeh"
                },
                {
                    "first": "Jon K.",
                    "initial": "J.K.",
                    "last": "Andrus"
                },
                {
                    "first": "Colin",
                    "initial": "C.",
                    "last": "Sanderson"
                }
            ],
            "doi": "10.1016/j.vaccine.2013.05.045",
            "firstpage": "C19",
            "issn": "0264410X",
            "lastpage": "C29",
            "pmid": "23777686",
            "pub_year": 2013,
            "title": "TRIVAC decision-support model for evaluating the cost-effectiveness of Haemophilus influenzae type b, pneumococcal and rotavirus vaccination",
            "volume": "31"
        },
        "b0095": null,
        "b0100": null,
        "b0105": {
            "authors": [
                {
                    "first": "Altanchimeg",
                    "initial": "A.",
                    "last": "Samdan"
                },
                {
                    "first": "Sarangua",
                    "initial": "S.",
                    "last": "Ganbold"
                },
                {
                    "first": "Oyunchimeg",
                    "initial": "O.",
                    "last": "Guntev"
                },
                {
                    "first": "Solongo",
                    "initial": "S.",
                    "last": "Orosoo"
                },
                {
                    "first": "Narmandakh",
                    "initial": "N.",
                    "last": "Javzandorj"
                },
                {
                    "first": "Amar",
                    "initial": "A.",
                    "last": "Gongor"
                },
                {
                    "first": "Altansukh",
                    "initial": "A.",
                    "last": "Enkhtuvshin"
                },
                {
                    "first": "Sodbayar",
                    "initial": "S.",
                    "last": "Demberelsuren"
                },
                {
                    "first": "Wajid",
                    "initial": "W.",
                    "last": "Abdul"
                },
                {
                    "first": "Youngmee",
                    "initial": "Y.",
                    "last": "Jee"
                },
                {
                    "first": "Varja",
                    "initial": "V.",
                    "last": "Grabovac"
                },
                {
                    "first": "Carl",
                    "initial": "C.",
                    "last": "Kirkwood"
                },
                {
                    "first": "Kimberley",
                    "initial": "K.",
                    "last": "Fox"
                },
                {
                    "first": "Batmunkh",
                    "initial": "B.",
                    "last": "Nyambat"
                }
            ],
            "doi": "10.1016/j.vaccine.2018.02.010",
            "firstpage": "7883",
            "issn": "0264410X",
            "lastpage": "7887",
            "pmid": "29429811",
            "pub_year": 2018,
            "title": "Hospital-based surveillance for rotavirus diarrhea in Ulaanbaatar, Mongolia, April 2009 through March 2016",
            "volume": "36"
        },
        "b0110": {
            "authors": [
                {
                    "first": "Andrew",
                    "initial": "A.",
                    "last": "Clark"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Black"
                },
                {
                    "first": "Jacqueline",
                    "initial": "J.",
                    "last": "Tate"
                },
                {
                    "first": "Anna",
                    "initial": "A.",
                    "last": "Roose"
                },
                {
                    "first": "Karen",
                    "initial": "K.",
                    "last": "Kotloff"
                },
                {
                    "first": "Diana",
                    "initial": "D.",
                    "last": "Lam"
                },
                {
                    "first": "William",
                    "initial": "W.",
                    "last": "Blackwelder"
                },
                {
                    "first": "Umesh",
                    "initial": "U.",
                    "last": "Parashar"
                },
                {
                    "first": "Claudio",
                    "initial": "C.",
                    "last": "Lanata"
                },
                {
                    "first": "Gagandeep",
                    "initial": "G.",
                    "last": "Kang"
                },
                {
                    "first": "Christopher",
                    "initial": "C.",
                    "last": "Troeger"
                },
                {
                    "first": "James",
                    "initial": "J.",
                    "last": "Platts-Mills"
                },
                {
                    "first": "Ali",
                    "initial": "A.",
                    "last": "Mokdad"
                },
                {
                    "first": "Colin",
                    "initial": "C.",
                    "last": "Sanderson"
                },
                {
                    "first": "Laura",
                    "initial": "L.",
                    "last": "Lamberti"
                },
                {
                    "first": "Myron",
                    "initial": "M.",
                    "last": "Levine"
                },
                {
                    "first": "Mathuram",
                    "initial": "M.",
                    "last": "Santosham"
                },
                {
                    "first": "Duncan",
                    "initial": "D.",
                    "last": "Steele"
                },
                {
                    "first": "Yati",
                    "initial": "Y.",
                    "last": "Soenarto"
                },
                {
                    "first": "Celse",
                    "initial": "C.",
                    "last": "Rugambwa"
                },
                {
                    "first": "Evans",
                    "initial": "E.",
                    "last": "Mpabalwani"
                },
                {
                    "first": "Jason",
                    "initial": "J.",
                    "last": "Mwenda"
                },
                {
                    "first": "Jill",
                    "initial": "J.",
                    "last": "Murray"
                },
                {
                    "first": "Adam",
                    "initial": "A.",
                    "last": "Cohen"
                },
                {
                    "first": null,
                    "initial": null,
                    "last": null
                }
            ],
            "doi": "10.1371/journal.pone.0183392",
            "issn": "19326203",
            "pmid": "28892480",
            "pub_year": 2017,
            "title": "Estimating global, regional and national rotavirus deaths in children aged <5 years: Current approaches, new analyses and proposed improvements",
            "volume": "12"
        },
        "b0115": {
            "authors": [
                {
                    "first": "Joke",
                    "initial": "J.",
                    "last": "Bilcke"
                },
                {
                    "first": "Pierre",
                    "initial": "P.",
                    "last": "Van Damme"
                },
                {
                    "first": "Marc",
                    "initial": "M.",
                    "last": "Van Ranst"
                },
                {
                    "first": "Niel",
                    "initial": "N.",
                    "last": "Hens"
                },
                {
                    "first": "Marc",
                    "initial": "M.",
                    "last": "Aerts"
                },
                {
                    "first": "Philippe",
                    "initial": "P.",
                    "last": "Beutels"
                }
            ],
            "doi": "10.1371/journal.pone.0006060",
            "issn": "19326203",
            "pmid": "19557133",
            "pub_year": 2009,
            "title": "Estimating the incidence of symptomatic rotavirus infections: A systematic review and meta-analysis",
            "volume": "4"
        },
        "b0120": {
            "authors": [
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Zaman"
                },
                {
                    "first": "Dang Duc",
                    "initial": "D.D.",
                    "last": "Anh"
                },
                {
                    "first": "John C.",
                    "initial": "J.C.",
                    "last": "Victor"
                },
                {
                    "first": "Sunheang",
                    "initial": "S.",
                    "last": "Shin"
                },
                {
                    "first": "Md",
                    "initial": "M.",
                    "last": "Yunus"
                },
                {
                    "first": "Michael J.",
                    "initial": "M.J.",
                    "last": "Dallas"
                },
                {
                    "first": "Goutam",
                    "initial": "G.",
                    "last": "Podder"
                },
                {
                    "first": "Vu Dinh",
                    "initial": "V.D.",
                    "last": "Thiem"
                },
                {
                    "first": "Le Thi Phuong",
                    "initial": "L.T.P.",
                    "last": "Mai"
                },
                {
                    "first": "Stephen P.",
                    "initial": "S.P.",
                    "last": "Luby"
                },
                {
                    "first": "Le Huu",
                    "initial": "L.H.",
                    "last": "Tho"
                },
                {
                    "first": "Michele L.",
                    "initial": "M.L.",
                    "last": "Coia"
                },
                {
                    "first": "Kristen",
                    "initial": "K.",
                    "last": "Lewis"
                },
                {
                    "first": "Stephen B.",
                    "initial": "S.B.",
                    "last": "Rivers"
                },
                {
                    "first": "David A.",
                    "initial": "D.A.",
                    "last": "Sack"
                },
                {
                    "first": "Florian",
                    "initial": "F.",
                    "last": "Sch\u00f6del"
                },
                {
                    "first": "A. Duncan",
                    "initial": "A.D.",
                    "last": "Steele"
                },
                {
                    "first": "Kathleen M.",
                    "initial": "K.M.",
                    "last": "Neuzil"
                },
                {
                    "first": "Max",
                    "initial": "M.",
                    "last": "Ciarlet"
                }
            ],
            "doi": "10.1016/S0140-6736(10)60755-6",
            "firstpage": "615",
            "issn": "01406736",
            "lastpage": "623",
            "pmid": "20692031",
            "pub_year": 2010,
            "title": "Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: A randomised, double-blind, placebo-controlled trial",
            "volume": "376"
        },
        "b0125": {
            "authors": [
                {
                    "first": "Renat",
                    "initial": "R.",
                    "last": "Latipov"
                },
                {
                    "first": "Elmira",
                    "initial": "E.",
                    "last": "Utegenova"
                },
                {
                    "first": "Aynagul",
                    "initial": "A.",
                    "last": "Kuatbayeva"
                },
                {
                    "first": "Kaliya",
                    "initial": "K.",
                    "last": "Kasymbekova"
                },
                {
                    "first": "Sabyrjan",
                    "initial": "S.",
                    "last": "Abdykarimov"
                },
                {
                    "first": "Rivojiddin",
                    "initial": "R.",
                    "last": "Juraev"
                },
                {
                    "first": "Umid",
                    "initial": "U.",
                    "last": "Ismailov"
                },
                {
                    "first": "Elmira",
                    "initial": "E.",
                    "last": "Flem"
                }
            ],
            "doi": "10.1016/j.ijid.2011.03.014",
            "firstpage": "e464",
            "issn": "12019712",
            "lastpage": "e469",
            "pmid": "21524932",
            "pub_year": 2011,
            "title": "Epidemiology and burden of rotavirus disease in Central Asia",
            "volume": "15"
        },
        "b0130": {
            "authors": [
                {
                    "first": "Elmira T.",
                    "initial": "E.T.",
                    "last": "Flem"
                },
                {
                    "first": "Renat",
                    "initial": "R.",
                    "last": "Latipov"
                },
                {
                    "first": "Zuridin S.",
                    "initial": "Z.S.",
                    "last": "Nurmatov"
                },
                {
                    "first": "Yiting",
                    "initial": "Y.",
                    "last": "Xue"
                },
                {
                    "first": "Kaliya T.",
                    "initial": "K.T.",
                    "last": "Kasymbekova"
                },
                {
                    "first": "Richard D.",
                    "initial": "R.D.",
                    "last": "Rheingans"
                }
            ],
            "doi": "10.1086/605040",
            "firstpage": "S195",
            "issn": "00221899",
            "lastpage": "S202",
            "pmid": "19817600",
            "pub_year": 2009,
            "title": "Costs of diarrheal disease and the cost-effectiveness of a rotavirus vaccination program in Kyrgyzstan",
            "volume": "200"
        },
        "b0135": {
            "authors": [
                {
                    "first": "Joshua A.",
                    "initial": "J.A.",
                    "last": "Salomon"
                },
                {
                    "first": "Juanita A.",
                    "initial": "J.A.",
                    "last": "Haagsma"
                },
                {
                    "first": "Adrian",
                    "initial": "A.",
                    "last": "Davis"
                },
                {
                    "first": "Charline Maertens",
                    "initial": "C.M.",
                    "last": "de Noordhout"
                },
                {
                    "first": "Suzanne",
                    "initial": "S.",
                    "last": "Polinder"
                },
                {
                    "first": "Arie H.",
                    "initial": "A.H.",
                    "last": "Havelaar"
                },
                {
                    "first": "Alessandro",
                    "initial": "A.",
                    "last": "Cassini"
                },
                {
                    "first": "Brecht",
                    "initial": "B.",
                    "last": "Devleesschauwer"
                },
                {
                    "first": "Mirjam",
                    "initial": "M.",
                    "last": "Kretzschmar"
                },
                {
                    "first": "Niko",
                    "initial": "N.",
                    "last": "Speybroeck"
                },
                {
                    "first": "Christopher J.L.",
                    "initial": "C.J.L.",
                    "last": "Murray"
                },
                {
                    "first": "Theo",
                    "initial": "T.",
                    "last": "Vos"
                }
            ],
            "doi": "10.1016/S2214-109X(15)00069-8",
            "firstpage": "e712",
            "issn": "2214109X",
            "lastpage": "e723",
            "pmid": "26475018",
            "pub_year": 2015,
            "title": "Disability weights for the Global Burden of Disease 2013 study",
            "volume": "3"
        },
        "b0140": null,
        "b0145": null,
        "b0150": null,
        "b0155": null,
        "b0160": {
            "authors": [
                {
                    "first": "Clint",
                    "initial": "C.",
                    "last": "Pecenka"
                },
                {
                    "first": "Frederic",
                    "initial": "F.",
                    "last": "Debellut"
                },
                {
                    "first": "Naor",
                    "initial": "N.",
                    "last": "Bar-Zeev"
                },
                {
                    "first": "Palwasha",
                    "initial": "P.",
                    "last": "Anwari"
                },
                {
                    "first": "Justice",
                    "initial": "J.",
                    "last": "Nonvignon"
                },
                {
                    "first": "Md",
                    "initial": "M.",
                    "last": "Shamsuzzaman"
                },
                {
                    "first": "Andrew",
                    "initial": "A.",
                    "last": "Clark"
                }
            ],
            "doi": "10.1016/j.vaccine.2018.10.068",
            "firstpage": "7472",
            "issn": "0264410X",
            "lastpage": "7478",
            "pmid": "30420039",
            "pub_year": 2018,
            "title": "Re-evaluating the cost and cost-effectiveness of rotavirus vaccination in Bangladesh, Ghana, and Malawi: A comparison of three rotavirus vaccines",
            "volume": "36"
        },
        "b0165": null,
        "b0170": null,
        "b0175": null,
        "b0180": null,
        "b0185": null,
        "b0190": null,
        "b0195": null,
        "b0200": null,
        "b0205": null,
        "b0210": null,
        "b0215": null,
        "b0220": null,
        "b0225": null,
        "b0230": {
            "authors": [
                {
                    "first": "Neisha",
                    "initial": "N.",
                    "last": "Sundaram"
                },
                {
                    "first": "Cynthia",
                    "initial": "C.",
                    "last": "Chen"
                },
                {
                    "first": "Joanne",
                    "initial": "J.",
                    "last": "Yoong"
                },
                {
                    "first": "Munkh Erdene",
                    "initial": "M.E.",
                    "last": "Luvsan"
                },
                {
                    "first": "Kimberley",
                    "initial": "K.",
                    "last": "Fox"
                },
                {
                    "first": "Amarzaya",
                    "initial": "A.",
                    "last": "Sarankhuu"
                },
                {
                    "first": "Sophie",
                    "initial": "S.",
                    "last": "La Vincente"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Jit"
                }
            ],
            "doi": "10.1016/j.vaccine.2016.12.070",
            "firstpage": "1055",
            "issn": "0264410X",
            "lastpage": "1063",
            "pmid": "28109706",
            "pub_year": 2017,
            "title": "Cost-effectiveness of 13-valent pneumococcal conjugate vaccination in Mongolia",
            "volume": "35"
        },
        "b0235": {
            "authors": [
                {
                    "first": "Surachai",
                    "initial": "S.",
                    "last": "Kotirum"
                },
                {
                    "first": "Naaon",
                    "initial": "N.",
                    "last": "Vutipongsatorn"
                },
                {
                    "first": "Khachen",
                    "initial": "K.",
                    "last": "Kongpakwattana"
                },
                {
                    "first": "Raymond",
                    "initial": "R.",
                    "last": "Hutubessy"
                },
                {
                    "first": "Nathorn",
                    "initial": "N.",
                    "last": "Chaiyakunapruk"
                }
            ],
            "doi": "10.1016/j.vaccine.2017.04.051",
            "firstpage": "3364",
            "issn": "0264410X",
            "lastpage": "3386",
            "pmid": "28504193",
            "pub_year": 2017,
            "title": "Global economic evaluations of rotavirus vaccines: A systematic review",
            "volume": "35"
        },
        "b0240": {
            "authors": [
                {
                    "first": "Melanie Y.",
                    "initial": "M.Y.",
                    "last": "Bertram"
                },
                {
                    "first": "Jeremy A.",
                    "initial": "J.A.",
                    "last": "Lauer"
                },
                {
                    "first": "Kees",
                    "initial": "K.",
                    "last": "De Joncheere"
                },
                {
                    "first": "Tessa",
                    "initial": "T.",
                    "last": "Edejer"
                },
                {
                    "first": "Raymond",
                    "initial": "R.",
                    "last": "Hutubessy"
                },
                {
                    "first": "Marie Paule",
                    "initial": "M.P.",
                    "last": "Kieny"
                },
                {
                    "first": "Suzanne R.",
                    "initial": "S.R.",
                    "last": "Hill"
                }
            ],
            "doi": "10.2471/BLT.15.164418",
            "firstpage": "925",
            "issn": "00429686",
            "lastpage": "930",
            "pmid": "27994285",
            "pub_year": 2016,
            "title": "Cost-effectiveness thresholds: Pros and cons",
            "volume": "94"
        },
        "b0245": null
    },
    "body_text": [
        {
            "endOffset": 24696,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "All data inputs and assumptions were discussed and validated by a group of experts that participated in this cost-effectiveness analysis.",
            "startOffset": 24559,
            "title": "Model"
        },
        {
            "endOffset": 31471,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Based on a 2017 PATH literature review examining all diarrhea cost-of-illness studies reporting data for low- and middle-income countries, we calculated that direct medical costs accounted for 70% of all direct costs.",
            "startOffset": 31254,
            "title": "Health service costs"
        },
        {
            "endOffset": 30258,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0205": {
                    "endOffset": 30257,
                    "startOffset": 30250
                },
                "b0210": {
                    "endOffset": 30257,
                    "startOffset": 30250
                }
            },
            "secId": "s0030",
            "sentence": "We assume international handling and delivery of vaccines will represent 3.5% and 8% of vaccine price respectively [41,42].",
            "startOffset": 30135,
            "title": "Vaccine price and delivery cost"
        },
        {
            "endOffset": 38959,
            "parents": [],
            "secId": "s0060",
            "sentence": "This approach obliged us to assume a similar incremental health system cost for the delivery of several products.",
            "startOffset": 38846,
            "title": "Discussion"
        },
        {
            "endOffset": 38685,
            "parents": [],
            "secId": "s0060",
            "sentence": "In addition, the country was in the process of updating its comprehensive multi-year plan at the time of this analysis.",
            "startOffset": 38566,
            "title": "Discussion"
        },
        {
            "endOffset": 34847,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "The undiscounted results from the government perspective (Table 5) indicate that budget impact varies greatly depending on which vaccine is considered.",
            "startOffset": 34696,
            "title": "Additional scenarios and one-way sensitivity analyses"
        },
        {
            "endOffset": 23421,
            "parents": [],
            "secId": "s0010",
            "sentence": "We elected to use the discounted cost per averted DALY as our main outcome measure.",
            "startOffset": 23338,
            "title": "Materials and methods"
        },
        {
            "endOffset": 35186,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Accounting for savings on health care costs averted from the government perspective, the net cost of the vaccination program with ROTAVAC\u00ae would be less than $3.5 million over 10 years.",
            "startOffset": 35001,
            "title": "Additional scenarios and one-way sensitivity analyses"
        },
        {
            "endOffset": 31253,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0220": {
                    "endOffset": 31252,
                    "startOffset": 31248
                }
            },
            "secId": "s0035",
            "sentence": "Cost per outpatient visit is the sum of the WHO-CHOICE cost in a primary facility setting and 6 oral rehydration salts (ORS) packets per day for 3 days, valuing ORS solution at $0.29 per packet, per MSH\u2019s International Medical Products Price Guide [44].",
            "startOffset": 31000,
            "title": "Health service costs"
        },
        {
            "endOffset": 28025,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0150": {
                    "endOffset": 28024,
                    "startOffset": 28020
                }
            },
            "secId": "s0025",
            "sentence": "We assumed that timeliness of rotavirus vaccination would be similar to that for DTP reported in the 2013 Mongolia Multiple Indicator Cluster Survey (MICS) study [30].",
            "startOffset": 27858,
            "title": "Vaccine coverage and efficacy"
        },
        {
            "endOffset": 19176,
            "parents": [],
            "refoffsets": {
                "b0045": {
                    "endOffset": 19175,
                    "startOffset": 19169
                },
                "b0050": {
                    "endOffset": 19175,
                    "startOffset": 19169
                }
            },
            "secId": "s0005",
            "sentence": "Clinical trials and post-introduction evaluations have indicated vaccine efficacy and/or effectiveness ranges from approximately 70% to 100% in high- and upper-middle-income countries to approximately 50% to 70% in lower-income countries in Africa and Asia [9,10].",
            "startOffset": 18912,
            "title": "Introduction"
        },
        {
            "endOffset": 18022,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 18021,
                    "startOffset": 18018
                }
            },
            "secId": "s0005",
            "sentence": "In 2013, rotavirus was responsible for 215,000 of the 578,000 childhood diarrheal deaths worldwide with more than 90% of these deaths occurring in low- and middle-income countries [1].",
            "startOffset": 17838,
            "title": "Introduction"
        },
        {
            "endOffset": 32009,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "The study estimated household costs linked to an episode of diarrhea, accounting for households\u2019 preparation and transportation costs, and out-of-pocket payments prior to and during hospitalization.",
            "startOffset": 31811,
            "title": "Health service costs"
        },
        {
            "endOffset": 18439,
            "parents": [],
            "secId": "s0005",
            "sentence": "A 2013 social indicator sample survey reported a prevalence of diarrhea of 8.2% in children under five years, with higher prevalence in rural areas.",
            "startOffset": 18291,
            "title": "Introduction"
        },
        {
            "endOffset": 36710,
            "parents": [],
            "refoffsets": {
                "b0235": {
                    "endOffset": 36709,
                    "startOffset": 36705
                }
            },
            "secId": "s0060",
            "sentence": "In addition, many similar studies in middle-income settings found rotavirus vaccination to be a cost-effective intervention with ICERs ranging from cost saving to cost-effective [47].",
            "startOffset": 36527,
            "title": "Discussion"
        },
        {
            "endOffset": 20938,
            "parents": [],
            "secId": "s0005",
            "sentence": "The purpose of this evaluation is to estimate the potential impact, cost-effectiveness, and budget implications associated with infant rotavirus vaccination as part of the national immunization program in Mongolia compared to no vaccination, assessing the three different rotavirus products available at the time of writing, and to provide data needed to prepare for potential introduction.",
            "startOffset": 20548,
            "title": "Introduction"
        },
        {
            "endOffset": 27473,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0140": {
                    "endOffset": 27472,
                    "startOffset": 27468
                }
            },
            "secId": "s0020",
            "sentence": "We assumed the average duration of rotavirus disease to be 3 days for non-severe cases and 7 days for severe cases [28].",
            "startOffset": 27353,
            "title": "Disease burden"
        },
        {
            "endOffset": 23899,
            "parents": [],
            "secId": "s0010",
            "sentence": "This analysis examines budget implications, providing undiscounted annual costs of the vaccination program over the ten-year time horizon of the analysis.",
            "startOffset": 23745,
            "title": "Materials and methods"
        },
        {
            "endOffset": 35889,
            "parents": [],
            "refoffsets": {
                "b0225": {
                    "endOffset": 35888,
                    "startOffset": 35884
                }
            },
            "secId": "s0060",
            "sentence": "The cost per DALY averted by rotavirus vaccination represents 28% and 19% of the GDP per capita ($3694 in 2016) from the government and the societal perspectives, respectively [45].",
            "startOffset": 35708,
            "title": "Discussion"
        },
        {
            "endOffset": 31810,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Inpatient costs were estimated using a mix of local data available from an unpublished cost of rotavirus diarrhea study and modelled data based on 2010 WHO-CHOICE data.",
            "startOffset": 31642,
            "title": "Health service costs"
        },
        {
            "endOffset": 26922,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0115": {
                    "endOffset": 26756,
                    "startOffset": 26752
                },
                "b0120": {
                    "endOffset": 26921,
                    "startOffset": 26917
                }
            },
            "secId": "s0020",
            "sentence": "As a high input, we used 10,000 per 100,000 cases in children under five years as demonstrated by Bilcke et al. in a global systematic review and meta-analysis [23], which is consistent with the incidence level observed by Zaman et al. in the placebo arm of the RotaTeq\u00ae randomized controlled trial in Bangladesh and Vietnam [24].",
            "startOffset": 26592,
            "title": "Disease burden"
        },
        {
            "endOffset": 24212,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Developed for use in low- and middle-income countries, UNIVAC provides estimates of the potential impact and cost-effectiveness of rotavirus and other vaccines.",
            "startOffset": 24052,
            "title": "Model"
        },
        {
            "endOffset": 26591,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "To account for uncertainty, we examined other potential incidence rates.",
            "startOffset": 26519,
            "title": "Disease burden"
        },
        {
            "endOffset": 27790,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0145": {
                    "endOffset": 27789,
                    "startOffset": 27785
                }
            },
            "secId": "s0025",
            "sentence": "As rotavirus vaccine is anticipated to be delivered alongside DTP according to WHO recommendations, we use DTP coverage as reported by WHO and UNICEF, assuming constant coverage across the study period [29].",
            "startOffset": 27583,
            "title": "Vaccine coverage and efficacy"
        },
        {
            "endOffset": 29604,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0185": {
                    "endOffset": 29603,
                    "startOffset": 29599
                }
            },
            "secId": "s0030",
            "sentence": "As the potential outcome of this negotiation is uncertain, we used price data reported by other middle-income countries that do not access Gavi prices [37].",
            "startOffset": 29448,
            "title": "Vaccine price and delivery cost"
        },
        {
            "endOffset": 18215,
            "parents": [],
            "secId": "s0005",
            "sentence": "In Mongolia, the World Health Organization (WHO) and the Centers for Disease Control and Prevention estimated that over 50 children under five years of age die of rotavirus infection annually.",
            "startOffset": 18023,
            "title": "Introduction"
        },
        {
            "endOffset": 34591,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "From the societal perspective, the cost per DALY is $77 with ROTAVAC\u00ae and $635 with RotaTeq\u00ae.",
            "startOffset": 34498,
            "title": "Additional scenarios and one-way sensitivity analyses"
        },
        {
            "endOffset": 35553,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Vaccine coverage has no impact on the ICER as it affects costs and benefits equally.",
            "startOffset": 35469,
            "title": "Additional scenarios and one-way sensitivity analyses"
        },
        {
            "endOffset": 27551,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "All data inputs used to characterize disease burden are displayed in Table 1.",
            "startOffset": 27474,
            "title": "Disease burden"
        },
        {
            "endOffset": 28292,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0155": {
                    "endOffset": 28291,
                    "startOffset": 28287
                }
            },
            "secId": "s0025",
            "sentence": "Efficacy and waning inputs are based on work from Clark et al., who estimated efficacy of rotavirus vaccination by time since administration of the last dose, extracting data from all randomized controlled trials in very low-, low-, and high-mortality settings [31].",
            "startOffset": 28026,
            "title": "Vaccine coverage and efficacy"
        },
        {
            "endOffset": 33825,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "Additional details on health and economic benefits of rotavirus vaccination are available from Table 4.",
            "startOffset": 33722,
            "title": "Base case scenario"
        },
        {
            "endOffset": 22395,
            "parents": [],
            "secId": "s0010",
            "sentence": "Severe episodes result in recovery or death with or without outpatient and/or inpatient care (Fig. 1).",
            "startOffset": 22293,
            "title": "Materials and methods"
        },
        {
            "endOffset": 27857,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Coverage for DTP2 was assumed to be halfway between DTP1 and DTP3.",
            "startOffset": 27791,
            "title": "Vaccine coverage and efficacy"
        },
        {
            "endOffset": 38286,
            "parents": [],
            "secId": "s0060",
            "sentence": "Furthermore, because surveillance data were an important input into our incidence calculations, these data are also uncertain.",
            "startOffset": 38160,
            "title": "Discussion"
        },
        {
            "endOffset": 24309,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0090": {
                    "endOffset": 24308,
                    "startOffset": 24304
                }
            },
            "secId": "s0015",
            "sentence": "UNIVAC follows methods developed for the TRIVAC model, which have been described elsewhere [18].",
            "startOffset": 24213,
            "title": "Model"
        },
        {
            "endOffset": 22720,
            "parents": [],
            "secId": "s0010",
            "sentence": "We exclude any indirect benefits of vaccination, assuming herd effect would have minimal impact considering the high vaccine coverage in Mongolia.",
            "startOffset": 22574,
            "title": "Materials and methods"
        },
        {
            "endOffset": 32100,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "The study also collected information from medical records to assess hospital direct costs.",
            "startOffset": 32010,
            "title": "Health service costs"
        },
        {
            "endOffset": 24460,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Model inputs include burden of disease, vaccine schedule, efficacy, coverage, timeliness of vaccination, vaccine program costs, and health care costs.",
            "startOffset": 24310,
            "title": "Model"
        },
        {
            "endOffset": 34217,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "This amount would be partially balanced by savings made on health care costs averted, but with ROTARIX\u00ae at a price per dose of $6.20, the rotavirus vaccination program would still represent a net cost of about $850,000 on average per year.",
            "startOffset": 33978,
            "title": "Base case scenario"
        },
        {
            "endOffset": 38383,
            "parents": [],
            "secId": "s0060",
            "sentence": "Incidence and access to care data are critical inputs and are explored in the scenario analysis.",
            "startOffset": 38287,
            "title": "Discussion"
        },
        {
            "endOffset": 38845,
            "parents": [],
            "secId": "s0060",
            "sentence": "This made the assessment of incremental health system costs linked to rotavirus vaccination difficult so we elected to use internationally validated estimates.",
            "startOffset": 38686,
            "title": "Discussion"
        },
        {
            "endOffset": 23549,
            "parents": [],
            "secId": "s0010",
            "sentence": "DALYs are commonly use in cost-effectiveness analysis, partly because of their comparability across settings and interventions.",
            "startOffset": 23422,
            "title": "Materials and methods"
        },
        {
            "endOffset": 25598,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0095": {
                    "endOffset": 25597,
                    "startOffset": 25590
                },
                "b0100": {
                    "endOffset": 25597,
                    "startOffset": 25590
                }
            },
            "secId": "s0020",
            "sentence": "We first calculated rates of outpatient visits and hospitalizations using the number of diarrhea cases in children under five years (outpatient and inpatient) reported by the Center for Health Development and population data from the National Statistical Office [19,20].",
            "startOffset": 25328,
            "title": "Disease burden"
        },
        {
            "endOffset": 33027,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "All parameters range values used for the sensitivity analysis are available from Tables 1, 2 and 3.",
            "startOffset": 32928,
            "title": "Scenario analysis and sensitivity analysis"
        },
        {
            "endOffset": 18510,
            "parents": [],
            "refoffsets": {
                "b0035": {
                    "endOffset": 18509,
                    "startOffset": 18506
                }
            },
            "secId": "s0005",
            "sentence": "The highest period-prevalence is seen among children 12\u201323 months [7].",
            "startOffset": 18440,
            "title": "Introduction"
        },
        {
            "endOffset": 33311,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "This corresponds to approximately 19,000 undiscounted DALYs averted.",
            "startOffset": 33243,
            "title": "Base case scenario"
        },
        {
            "endOffset": 39538,
            "parents": [],
            "secId": "s0065",
            "sentence": "This work was supported by the Bill & Melinda Gates Foundation, Seattle, WA [grant number OPP1147721].",
            "startOffset": 39436,
            "title": "Source of funding"
        },
        {
            "endOffset": 37036,
            "parents": [],
            "refoffsets": {
                "b0240": {
                    "endOffset": 37035,
                    "startOffset": 37031
                }
            },
            "secId": "s0060",
            "sentence": "While the range of incremental cost-effectiveness ratio (ICER) values shows that rotavirus vaccination is likely to be a highly cost-effective intervention at most thresholds, other critical considerations around affordability, feasibility, and status of other new vaccine introductions should be part of decision-making [48].",
            "startOffset": 36710,
            "title": "Discussion"
        },
        {
            "endOffset": 22573,
            "parents": [],
            "secId": "s0010",
            "sentence": "This analysis tracks costs and benefits of rotavirus disease and rotavirus vaccination of infants over 10 consecutive birth cohorts following each cohort until they reach age 5.",
            "startOffset": 22396,
            "title": "Materials and methods"
        },
        {
            "endOffset": 28510,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "We further assumed that one dose of vaccine would confer half the efficacy of the last dose.",
            "startOffset": 28418,
            "title": "Vaccine coverage and efficacy"
        },
        {
            "endOffset": 29331,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0170": {
                    "endOffset": 29203,
                    "startOffset": 29199
                }
            },
            "secId": "s0030",
            "sentence": "Although Gavi-secured pricing agreements with manufacturers allow fully self-financing countries to benefit from Gavi-like prices for some vaccines [34], it does not automatically apply to Mongolia for use of ROTARIX\u00ae as the country did not adopt while still eligible for support.",
            "startOffset": 29051,
            "title": "Vaccine price and delivery cost"
        },
        {
            "endOffset": 19378,
            "parents": [],
            "refoffsets": {
                "b0055": {
                    "endOffset": 19377,
                    "startOffset": 19373
                }
            },
            "secId": "s0005",
            "sentence": "ROTAVAC\u00ae (Bharat Biotech International Limited, India), another monovalent vaccine, received WHO prequalification for use globally in early 2018 and has been licensed and used in India since 2017 [11].",
            "startOffset": 19177,
            "title": "Introduction"
        },
        {
            "endOffset": 35468,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "These drivers were consistent among products.",
            "startOffset": 35423,
            "title": "Additional scenarios and one-way sensitivity analyses"
        },
        {
            "endOffset": 33721,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "The use of ROTARIX\u00ae would result in a cost-effectiveness ratio of $1050 per DALY averted from the government perspective and $715 from the societal perspective.",
            "startOffset": 33561,
            "title": "Base case scenario"
        },
        {
            "endOffset": 32631,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "We examined scenarios assessing the use of other available rotavirus vaccines RotaTeq\u00ae and ROTAVAC\u00ae and also used univariate sensitivity analysis to highlight the main drivers of cost-effectiveness of rotavirus vaccination in Mongolia.",
            "startOffset": 32396,
            "title": "Scenario analysis and sensitivity analysis"
        },
        {
            "endOffset": 22783,
            "parents": [],
            "refoffsets": {
                "b0070": {
                    "endOffset": 22782,
                    "startOffset": 22778
                }
            },
            "secId": "s0010",
            "sentence": "Costs and benefits are discounted using a 3% annual rate [14].",
            "startOffset": 22721,
            "title": "Materials and methods"
        },
        {
            "endOffset": 34420,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "We also explored the use of RotaTeq\u00ae and ROTAVAC\u00ae vaccines instead of ROTARIX\u00ae.",
            "startOffset": 34341,
            "title": "Additional scenarios and one-way sensitivity analyses"
        },
        {
            "endOffset": 37429,
            "parents": [],
            "secId": "s0060",
            "sentence": "With ROTAVAC\u00ae, the vaccination program cost would likely be the lowest and the most affordable with a net cost approximately 70% lower than ROTARIX\u00ae and RotaTeq\u00ae.",
            "startOffset": 37267,
            "title": "Discussion"
        },
        {
            "endOffset": 25826,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0105": {
                    "endOffset": 25825,
                    "startOffset": 25821
                }
            },
            "secId": "s0020",
            "sentence": "We assumed all hospitalizations were for severe diarrhea and applied the rotavirus-attributable fraction observed among diarrhea admissions in two hospitals of Ulaanbaatar city reported by the surveillance network in 2015 [21].",
            "startOffset": 25599,
            "title": "Disease burden"
        },
        {
            "endOffset": 37772,
            "parents": [],
            "secId": "s0060",
            "sentence": "While product choice is a multifactorial decision and this is a single study, this analysis suggests that countries that cannot access Gavi-like prices for ROTARIX\u00ae and RotaTeq\u00ae may have an economic incentive to consider new products.",
            "startOffset": 37538,
            "title": "Discussion"
        },
        {
            "endOffset": 29652,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0190": {
                    "endOffset": 29651,
                    "startOffset": 29647
                }
            },
            "secId": "s0030",
            "sentence": "The average 2016 price was $6.20 per dose [38].",
            "startOffset": 29605,
            "title": "Vaccine price and delivery cost"
        },
        {
            "endOffset": 21525,
            "parents": [],
            "secId": "s0010",
            "sentence": "This analysis examines infant vaccination with ROTARIX\u00ae administered at 2 and 4 months along with Diphtheria, Tetanus, and Pertussis (DTP) at DTP dose 1 (DTP1) and DTP dose 2 (DTP2).",
            "startOffset": 21343,
            "title": "Materials and methods"
        },
        {
            "endOffset": 30649,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Data inputs used to estimate the vaccine program cost are available from Table 3.",
            "startOffset": 30568,
            "title": "Vaccine price and delivery cost"
        },
        {
            "endOffset": 36329,
            "parents": [],
            "secId": "s0060",
            "sentence": "While study results should be interpreted carefully, we believe that they present conservative estimates as we only explore the direct benefits of rotavirus vaccination.",
            "startOffset": 36160,
            "title": "Discussion"
        },
        {
            "endOffset": 22153,
            "parents": [],
            "secId": "s0010",
            "sentence": "When infected with rotavirus, children may or may not get rotavirus gastroenteritis (RVGE).",
            "startOffset": 22062,
            "title": "Materials and methods"
        },
        {
            "endOffset": 20351,
            "parents": [],
            "secId": "s0005",
            "sentence": "As a transitioned country, Mongolia cannot automatically access Gavi-negotiated prices for ROTARIX\u00ae, the most common product choice among Gavi countries.",
            "startOffset": 20198,
            "title": "Introduction"
        },
        {
            "endOffset": 38038,
            "parents": [],
            "secId": "s0060",
            "sentence": "As a consequence, there is limited local data on non-severe rotavirus disease and we had to rely on uncertain assumptions regarding access to care.",
            "startOffset": 37891,
            "title": "Discussion"
        },
        {
            "endOffset": 34696,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "From the government perspective, the cost per DALY averted is $412 with ROTAVAC\u00ae and $970 with RotaTeq\u00ae.",
            "startOffset": 34592,
            "title": "Additional scenarios and one-way sensitivity analyses"
        },
        {
            "endOffset": 17837,
            "parents": [],
            "secId": "s0005",
            "sentence": "However, diarrhea remains a primary cause of mortality, and rotavirus is responsible for a large share of these deaths.",
            "startOffset": 17718,
            "title": "Introduction"
        },
        {
            "endOffset": 21828,
            "parents": [],
            "secId": "s0010",
            "sentence": "We compare the impact and cost-effectiveness of rotavirus vaccination to no vaccination, over a ten-year time period starting in 2019.",
            "startOffset": 21694,
            "title": "Materials and methods"
        },
        {
            "endOffset": 19924,
            "parents": [],
            "secId": "s0005",
            "sentence": "Since 2009, Mongolia has participated in the WHO Western Pacific Regional Office rotavirus surveillance network to collect data on the rotavirus-positive proportion of diarrhea cases admitted to hospitals.",
            "startOffset": 19719,
            "title": "Introduction"
        },
        {
            "endOffset": 18290,
            "parents": [],
            "refoffsets": {
                "b0010": {
                    "endOffset": 18289,
                    "startOffset": 18284
                },
                "b0015": {
                    "endOffset": 18289,
                    "startOffset": 18284
                },
                "b0020": {
                    "endOffset": 18289,
                    "startOffset": 18284
                },
                "b0025": {
                    "endOffset": 18289,
                    "startOffset": 18284
                },
                "b0030": {
                    "endOffset": 18289,
                    "startOffset": 18284
                }
            },
            "secId": "s0005",
            "sentence": "Diarrhea is also a leading cause of childhood morbidity in Mongolia [2\u20136].",
            "startOffset": 18216,
            "title": "Introduction"
        },
        {
            "endOffset": 30800,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Outpatient cost estimates were based on WHO-CHOICE service delivery unit cost estimates for Mongolia as well as commodity costs.",
            "startOffset": 30672,
            "title": "Health service costs"
        },
        {
            "endOffset": 20100,
            "parents": [],
            "refoffsets": {
                "b0065": {
                    "endOffset": 20099,
                    "startOffset": 20095
                }
            },
            "secId": "s0005",
            "sentence": "In addition, Mongolia\u2019s comprehensive multi-year plan recommends that rotavirus vaccines be considered for the routine childhood immunization schedule in the near future [13].",
            "startOffset": 19925,
            "title": "Introduction"
        },
        {
            "endOffset": 29050,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0165": {
                    "endOffset": 29049,
                    "startOffset": 29045
                }
            },
            "secId": "s0030",
            "sentence": "Mongolia transitioned out of support from Gavi, the Vaccine Alliance in 2016 and now fully self-finances new vaccines [33].",
            "startOffset": 28927,
            "title": "Vaccine price and delivery cost"
        },
        {
            "endOffset": 37890,
            "parents": [],
            "secId": "s0060",
            "sentence": "First, the surveillance in Mongolia focuses on hospitalized cases only.",
            "startOffset": 37819,
            "title": "Discussion"
        },
        {
            "endOffset": 32351,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "We estimated the government cost of an inpatient stay at $77.93 and the households cost at $96.27 (Table 3).",
            "startOffset": 32243,
            "title": "Health service costs"
        },
        {
            "endOffset": 27059,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0125": {
                    "endOffset": 27058,
                    "startOffset": 27051
                },
                "b0130": {
                    "endOffset": 27058,
                    "startOffset": 27051
                }
            },
            "secId": "s0020",
            "sentence": "As a low input, we used our base case assumptions accounting for rotavirus positivity observed in other countries of the region [25,26].",
            "startOffset": 26923,
            "title": "Disease burden"
        },
        {
            "endOffset": 30917,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "We assumed government cost encompasses direct medical cost, while households cost includes direct non-medical costs.",
            "startOffset": 30801,
            "title": "Health service costs"
        },
        {
            "endOffset": 17717,
            "parents": [],
            "secId": "s0005",
            "sentence": "Child mortality has been declining worldwide as a result of socioeconomic development and child survival interventions.",
            "startOffset": 17598,
            "title": "Introduction"
        },
        {
            "endOffset": 25173,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "We estimated severe and non-severe RVGE cases, outpatient visits, and hospitalizations in Mongolia using data from different sources.",
            "startOffset": 25040,
            "title": "Disease burden"
        },
        {
            "endOffset": 38565,
            "parents": [],
            "refoffsets": {
                "b0245": {
                    "endOffset": 38564,
                    "startOffset": 38560
                }
            },
            "secId": "s0060",
            "sentence": "Second, assessing the cost linked to the immunization program was challenging, as immunization program costs in Mongolia are often integrated into more general cost categories [49].",
            "startOffset": 38384,
            "title": "Discussion"
        },
        {
            "endOffset": 19718,
            "parents": [],
            "secId": "s0005",
            "sentence": "One of the objectives of Mongolia\u2019s National Program on Infectious Diseases Prevention and Control is to use surveillance-based evidence to inform decision-making around new vaccine introduction.",
            "startOffset": 19523,
            "title": "Introduction"
        },
        {
            "endOffset": 28893,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Input parameters for vaccine coverage, timeliness, and vaccine impact are available from Table 2.",
            "startOffset": 28796,
            "title": "Vaccine coverage and efficacy"
        },
        {
            "endOffset": 34497,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Fig. 3 presents the cost per DALY averted for each scenario and perspective.",
            "startOffset": 34421,
            "title": "Additional scenarios and one-way sensitivity analyses"
        },
        {
            "endOffset": 38159,
            "parents": [],
            "secId": "s0060",
            "sentence": "The study, therefore, may not capture all non-severe cases and may underestimate the costs related to non-severe visits.",
            "startOffset": 38039,
            "title": "Discussion"
        },
        {
            "endOffset": 36032,
            "parents": [],
            "secId": "s0060",
            "sentence": "WHO no longer recommend to compare the ICER to GDP per capita and Mongolia has not yet defined a country specific threshold that we could use.",
            "startOffset": 35890,
            "title": "Discussion"
        },
        {
            "endOffset": 25023,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The group of experts included members from the Expanded Programme on Immunization and the National Center for Communicable Diseases; staff from the Sukhbaatar district surveillance hospital; the surveillance department of the National Maternal and Child Disease Center; the National Center for Health Development; and the WHO.",
            "startOffset": 24697,
            "title": "Model"
        },
        {
            "endOffset": 36159,
            "parents": [],
            "refoffsets": {
                "b0230": {
                    "endOffset": 36158,
                    "startOffset": 36154
                }
            },
            "secId": "s0060",
            "sentence": "In an attempt to allow for comparability, we elected to compare ICER to GDP per capita as done previously in the country [46].",
            "startOffset": 36033,
            "title": "Discussion"
        },
        {
            "endOffset": 28795,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Per model input requirements, the same efficacy value is applied to all endpoints.",
            "startOffset": 28713,
            "title": "Vaccine coverage and efficacy"
        },
        {
            "endOffset": 24558,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Input parameters were collected from the literature and local sources to reflect country context.",
            "startOffset": 24461,
            "title": "Model"
        },
        {
            "endOffset": 35309,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Results of the one-way sensitivity analysis show that vaccine price is a key driver of uncertainty of the results (Fig. 4).",
            "startOffset": 35186,
            "title": "Additional scenarios and one-way sensitivity analyses"
        },
        {
            "endOffset": 37266,
            "parents": [],
            "secId": "s0060",
            "sentence": "While ROTARIX\u00ae and RotaTeq\u00ae are relatively similar from a cost perspective, there is an economic argument for Mongolia to choose ROTAVAC\u00ae for a potential introduction.",
            "startOffset": 37099,
            "title": "Discussion"
        },
        {
            "endOffset": 28712,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0160": {
                    "endOffset": 28711,
                    "startOffset": 28707
                }
            },
            "secId": "s0025",
            "sentence": "In the absence of data to support different efficacy for different rotavirus vaccines, we assume similar efficacy and waning level for ROTARIX\u00ae, RotaTeq\u00ae and ROTAVAC\u00ae, as done in similar analyses [32].",
            "startOffset": 28511,
            "title": "Vaccine coverage and efficacy"
        },
        {
            "endOffset": 18911,
            "parents": [],
            "secId": "s0005",
            "sentence": "Two rotavirus vaccines have been licensed and used globally: the monovalent vaccine ROTARIX\u00ae (GlaxoSmithKline Biologicals, Rixensart, Belgium) and the pentavalent vaccine RotaTeq\u00ae (Merck & Co, Inc., West Point, PA, USA).",
            "startOffset": 18691,
            "title": "Introduction"
        },
        {
            "endOffset": 31537,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "We applied this percentage to calculate direct non-medical costs.",
            "startOffset": 31472,
            "title": "Health service costs"
        },
        {
            "endOffset": 29447,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0175": {
                    "endOffset": 29446,
                    "startOffset": 29439
                },
                "b0180": {
                    "endOffset": 29446,
                    "startOffset": 29439
                }
            },
            "secId": "s0030",
            "sentence": "To introduce ROTARIX\u00ae, the Mongolian government will have to enter into negotiations with the manufacturer [35,36].",
            "startOffset": 29332,
            "title": "Vaccine price and delivery cost"
        },
        {
            "endOffset": 32242,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "This information was combined with WHO-CHOICE data on bed day costs at a secondary level hospital for Mongolia and a four-day length of stay.",
            "startOffset": 32101,
            "title": "Health service costs"
        },
        {
            "endOffset": 21693,
            "parents": [],
            "secId": "s0010",
            "sentence": "We also examine ROTAVAC\u00ae and RotaTeq\u00ae vaccines administered to the same group, following the same schedule, with a third dose at 6 months along with DTP dose 3 (DTP3).",
            "startOffset": 21526,
            "title": "Materials and methods"
        },
        {
            "endOffset": 32927,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Parameters explored in the sensitivity analysis include incidence of severe RVGE hospitalizations, incidence of RVGE deaths, vaccine efficacy, vaccine coverage, vaccine price per dose, incremental health system cost per dose, inpatient admission costs, outpatient visit costs, and discount rate.",
            "startOffset": 32632,
            "title": "Scenario analysis and sensitivity analysis"
        },
        {
            "endOffset": 33242,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "Between 2019 and 2028, a rotavirus vaccination program in Mongolia has the potential to prevent more than 62,000 non-severe RVGE cases, approximately 34,000 severe cases, and 271 deaths.",
            "startOffset": 33056,
            "title": "Base case scenario"
        },
        {
            "endOffset": 22855,
            "parents": [],
            "secId": "s0010",
            "sentence": "Results are presented from the government and the societal perspective.",
            "startOffset": 22784,
            "title": "Materials and methods"
        },
        {
            "endOffset": 33977,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "The cost of the vaccination program is projected to average $1.1 million per year, with the majority of the cost dedicated to vaccine procurement (79%).",
            "startOffset": 33825,
            "title": "Base case scenario"
        },
        {
            "endOffset": 27352,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0135": {
                    "endOffset": 27351,
                    "startOffset": 27347
                }
            },
            "secId": "s0020",
            "sentence": "DALY weights for moderate and severe diarrhea in 2013 were 0.188 and 0.247, respectively [27].",
            "startOffset": 27258,
            "title": "Disease burden"
        },
        {
            "endOffset": 35707,
            "parents": [],
            "secId": "s0060",
            "sentence": "Our analysis shows that rotavirus vaccination in Mongolia has the potential to avert a substantial disease burden and be highly cost-effective.",
            "startOffset": 35564,
            "title": "Discussion"
        },
        {
            "endOffset": 30999,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "We did not include indirect costs, a conservative assumption due to lack of data.",
            "startOffset": 30918,
            "title": "Health service costs"
        },
        {
            "endOffset": 29849,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "In addition to vaccine price, we included procurement of safe disposal bags at a unit price of $0.80.",
            "startOffset": 29748,
            "title": "Vaccine price and delivery cost"
        },
        {
            "endOffset": 23744,
            "parents": [],
            "secId": "s0010",
            "sentence": "Additional outcomes measured include the number of deaths, hospitalizations, outpatient visits, and cases averted; the incremental cost of the vaccination program; and health care costs averted.",
            "startOffset": 23550,
            "title": "Materials and methods"
        },
        {
            "endOffset": 26341,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0035": {
                    "endOffset": 26211,
                    "startOffset": 26208
                }
            },
            "secId": "s0020",
            "sentence": "After obtaining estimates of health facility utilization, we then calculated incidence of RVGE as 4729 per 100,000 children under five years, using a treatment seeking rate of 46.8% for outpatient visits [7] and a rate of 80% for hospitalizations, assuming that a larger proportion of severe cases seek treatment in an inpatient setting.",
            "startOffset": 26004,
            "title": "Disease burden"
        },
        {
            "endOffset": 19523,
            "parents": [],
            "refoffsets": {
                "b0060": {
                    "endOffset": 19522,
                    "startOffset": 19518
                }
            },
            "secId": "s0005",
            "sentence": "Data from a clinical trial in India, a lower-middle-income setting where efficacy is expected to be lower, showed 56% efficacy of ROTAVAC\u00ae [12].",
            "startOffset": 19379,
            "title": "Introduction"
        },
        {
            "endOffset": 26518,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Local information suggests that children often visit an outpatient setting before being hospitalized, resulting in facility utilization that exceeds the number of severe cases.",
            "startOffset": 26342,
            "title": "Disease burden"
        },
        {
            "endOffset": 39419,
            "parents": [],
            "secId": "s0060",
            "sentence": "As Mongolia weighs the decision to introduce rotavirus vaccine into its routine childhood immunization schedule, the results of this analysis suggest that a rotavirus vaccination program will avert substantial disease burden and will likely be highly cost-effective in Mongolia.",
            "startOffset": 39141,
            "title": "Discussion"
        },
        {
            "endOffset": 27257,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0105": {
                    "endOffset": 27256,
                    "startOffset": 27252
                }
            },
            "secId": "s0020",
            "sentence": "Disease event age distribution is based on surveillance data [21].",
            "startOffset": 27191,
            "title": "Disease burden"
        },
        {
            "endOffset": 22292,
            "parents": [],
            "secId": "s0010",
            "sentence": "Non-severe episodes result in recovery with or without outpatient care.",
            "startOffset": 22221,
            "title": "Materials and methods"
        },
        {
            "endOffset": 35000,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "While ROTARIX\u00ae and RotaTeq\u00ae represent a total vaccination program cost of almost $11 million, ROTAVAC\u00ae results in a much lower cost of about $6 million.",
            "startOffset": 34848,
            "title": "Additional scenarios and one-way sensitivity analyses"
        },
        {
            "endOffset": 30134,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0055": {
                    "endOffset": 30133,
                    "startOffset": 30126
                },
                "b0200": {
                    "endOffset": 30133,
                    "startOffset": 30126
                }
            },
            "secId": "s0030",
            "sentence": "While ROTARIX\u00ae and RotaTeq\u00ae have a single dose presentation, ROTAVAC\u00ae is available in 10- or 5-dose vial, potentially generating higher wastage [11,40].",
            "startOffset": 29982,
            "title": "Vaccine price and delivery cost"
        },
        {
            "endOffset": 27190,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0005": {
                    "endOffset": 27189,
                    "startOffset": 27186
                }
            },
            "secId": "s0020",
            "sentence": "We used a disease mortality rate of 18 per 100,000 (16.5\u201320) per year in children under five years as reported by Tate et al. [1].",
            "startOffset": 27060,
            "title": "Disease burden"
        },
        {
            "endOffset": 20547,
            "parents": [],
            "secId": "s0005",
            "sentence": "In this situation, impact, cost-effectiveness, affordability, and budget impact are among the key factors to inform decisions around introducing rotavirus vaccination and which product to choose.",
            "startOffset": 20352,
            "title": "Introduction"
        },
        {
            "endOffset": 23094,
            "parents": [],
            "secId": "s0010",
            "sentence": "All monetary units were adjusted to 2017 US$ using currency exchange rate from the Central Bank of Mongolia (US$ 1 = MNT 2438) and the U.S. Consumer Price Index (CPI) from the United States Department of Labor, Bureau of Labor Statistics.",
            "startOffset": 22856,
            "title": "Materials and methods"
        },
        {
            "endOffset": 23337,
            "parents": [],
            "secId": "s0010",
            "sentence": "We calculate the incremental cost-effectiveness ratio (ICER) by dividing the difference between incremental vaccine program costs and averted health care costs by the number of disability-adjusted life-years (DALY) averted by the intervention.",
            "startOffset": 23094,
            "title": "Materials and methods"
        },
        {
            "endOffset": 21081,
            "parents": [],
            "secId": "s0010",
            "sentence": "The immunization program in Mongolia has been very successful at maintaining very high coverage for traditional antigens.",
            "startOffset": 20960,
            "title": "Materials and methods"
        },
        {
            "endOffset": 36526,
            "parents": [],
            "refoffsets": {
                "b0230": {
                    "endOffset": 36525,
                    "startOffset": 36521
                }
            },
            "secId": "s0060",
            "sentence": "A prior cost-effectiveness study found that pneumococcal conjugate vaccination at the Gavi price would be highly cost-effective in Mongolia, similar to our findings for rotavirus vaccination [46].",
            "startOffset": 36330,
            "title": "Discussion"
        },
        {
            "endOffset": 26003,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0110": {
                    "endOffset": 26002,
                    "startOffset": 25998
                }
            },
            "secId": "s0020",
            "sentence": "As rotavirus positivity is usually lower in outpatient settings, we applied half the rotavirus-attributable fraction to determine non-severe RVGE relative to all diarrhea [22].",
            "startOffset": 25827,
            "title": "Disease burden"
        },
        {
            "endOffset": 37098,
            "parents": [],
            "secId": "s0060",
            "sentence": "Budget impact varies depending on which vaccine is considered.",
            "startOffset": 37036,
            "title": "Discussion"
        },
        {
            "endOffset": 39609,
            "parents": [],
            "secId": "s0070",
            "sentence": "The authors have no conflicts to declare.",
            "startOffset": 39568,
            "title": "Conflict of interest statement"
        },
        {
            "endOffset": 21343,
            "parents": [],
            "refoffsets": {
                "b0065": {
                    "endOffset": 21342,
                    "startOffset": 21338
                }
            },
            "secId": "s0010",
            "sentence": "While the Ministry of Health is responsible for policy making and setting health regulations, immunization services are part of the health services provided by local governments and city corporations in district health facilities and family health centers [13].",
            "startOffset": 21082,
            "title": "Materials and methods"
        },
        {
            "endOffset": 30567,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0215": {
                    "endOffset": 30566,
                    "startOffset": 30562
                }
            },
            "secId": "s0030",
            "sentence": "We use data from a 2018 systematic review on the cost of immunization programs, using incremental cost-per-dose estimates reported by middle-income countries [43].",
            "startOffset": 30404,
            "title": "Vaccine price and delivery cost"
        },
        {
            "endOffset": 35422,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Other drivers of uncertainty include the inpatient admission costs and the rate of severe RVGE hospitalizations.",
            "startOffset": 35310,
            "title": "Additional scenarios and one-way sensitivity analyses"
        },
        {
            "endOffset": 31642,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "We estimated the government cost of an outpatient visit at $7.29 and households cost at $2.64 (Table 3).",
            "startOffset": 31538,
            "title": "Health service costs"
        },
        {
            "endOffset": 20197,
            "parents": [],
            "secId": "s0005",
            "sentence": "Mongolia recently transitioned from Gavi support and has to fully self-finance any new vaccines.",
            "startOffset": 20101,
            "title": "Introduction"
        },
        {
            "endOffset": 37818,
            "parents": [],
            "secId": "s0060",
            "sentence": "There are several limitations to our analysis.",
            "startOffset": 37772,
            "title": "Discussion"
        },
        {
            "endOffset": 25327,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "In the absence of RVGE incidence data, we based our estimates on health facility data and then adjusted for treatment seeking to estimate RVGE incidence.",
            "startOffset": 25174,
            "title": "Disease burden"
        },
        {
            "endOffset": 29748,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0170": {
                    "endOffset": 29747,
                    "startOffset": 29740
                },
                "b0195": {
                    "endOffset": 29747,
                    "startOffset": 29740
                }
            },
            "secId": "s0030",
            "sentence": "We utilized prices of $1.00 and $3.50 per dose for ROTAVAC\u00ae and RotaTeq\u00ae, respectively [34,39].",
            "startOffset": 29653,
            "title": "Vaccine price and delivery cost"
        },
        {
            "endOffset": 37537,
            "parents": [],
            "secId": "s0060",
            "sentence": "To our knowledge, this is the first analysis that demonstrates such a clear economic argument for ROTAVAC\u00ae.",
            "startOffset": 37430,
            "title": "Discussion"
        },
        {
            "endOffset": 29981,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "We assume a standard wastage rate of 5% for ROTARIX\u00ae and RotaTeq\u00ae and 25% for ROTAVAC\u00ae, based on the number of doses per container.",
            "startOffset": 29850,
            "title": "Vaccine price and delivery cost"
        },
        {
            "endOffset": 39141,
            "parents": [],
            "secId": "s0060",
            "sentence": "This is a critical consideration when considering alternative products, and we were not able to capture cost differentials linked to specific product characteristics such as volume.",
            "startOffset": 38960,
            "title": "Discussion"
        },
        {
            "endOffset": 39799,
            "parents": [],
            "secId": "s0075",
            "sentence": "The findings and conclusions of this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention (CDC).",
            "startOffset": 39619,
            "title": "Disclaimer"
        },
        {
            "endOffset": 33560,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "We estimate that rotavirus vaccination would avert 44,900 outpatient visits and more than 27,000 hospitalizations, representing $2.4 and $5 million in undiscounted health care costs saved from the government and societal perspectives, respectively.",
            "startOffset": 33312,
            "title": "Base case scenario"
        },
        {
            "endOffset": 28417,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Mongolia data inputs correspond to low child mortality and 81% (62% \u2212 87%) efficacy two weeks after receiving the last dose.",
            "startOffset": 28293,
            "title": "Vaccine coverage and efficacy"
        },
        {
            "endOffset": 30403,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "To our knowledge, no costing study has been carried out in Mongolia to inform the incremental health system cost of delivering rotavirus vaccine.",
            "startOffset": 30258,
            "title": "Vaccine price and delivery cost"
        },
        {
            "endOffset": 18690,
            "parents": [],
            "refoffsets": {
                "b0040": {
                    "endOffset": 18689,
                    "startOffset": 18686
                }
            },
            "secId": "s0005",
            "sentence": "Since 2009, WHO has recommended rotavirus vaccines to be included in national immunization programs as part of a comprehensive strategy to control childhood diarrheal diseases [8].",
            "startOffset": 18510,
            "title": "Introduction"
        },
        {
            "endOffset": 22062,
            "parents": [],
            "secId": "s0010",
            "sentence": "Our analysis viewed 2019 as a potential timeline for starting a rotavirus vaccination program if it became a priority based on other ongoing immunization activities and looks at ten years to inform medium term planning and budgeting.",
            "startOffset": 21829,
            "title": "Materials and methods"
        },
        {
            "endOffset": 22220,
            "parents": [],
            "secId": "s0010",
            "sentence": "Children with RVGE will experience a non-severe or severe episode.",
            "startOffset": 22154,
            "title": "Materials and methods"
        },
        {
            "endOffset": 24051,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0075": {
                    "endOffset": 24050,
                    "startOffset": 24043
                },
                "b0080": {
                    "endOffset": 24050,
                    "startOffset": 24043
                },
                "b0085": {
                    "endOffset": 24050,
                    "startOffset": 24043
                },
                "b0090": {
                    "endOffset": 24050,
                    "startOffset": 24043
                }
            },
            "secId": "s0015",
            "sentence": "We used UNIVAC (version 1.3.07), a universal static impact and cost-effectiveness decision support model used in many studies worldwide [15\u201318].",
            "startOffset": 23907,
            "title": "Model"
        },
        {
            "endOffset": 34285,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "Fig. 2 shows the anticipated base case budget implications by year.",
            "startOffset": 34218,
            "title": "Base case scenario"
        }
    ],
    "docId": "S0264410X19300258",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": null,
                "first": "Munkh Erdene",
                "initial": "M.E.",
                "last": "Lusvan"
            },
            {
                "email": "fdebellut@path.org",
                "first": "Fr\u00e9d\u00e9ric",
                "initial": "F.",
                "last": "Debellut"
            },
            {
                "email": null,
                "first": "Andrew",
                "initial": "A.",
                "last": "Clark"
            },
            {
                "email": null,
                "first": "Sodbayar",
                "initial": "S.",
                "last": "Demberelsuren"
            },
            {
                "email": null,
                "first": "Dashpagam",
                "initial": "D.",
                "last": "Otgonbayar"
            },
            {
                "email": null,
                "first": "Tselkhaasuren",
                "initial": "T.",
                "last": "Batjargal"
            },
            {
                "email": null,
                "first": "Sugarmaa",
                "initial": "S.",
                "last": "Purevsuren"
            },
            {
                "email": null,
                "first": "Devin",
                "initial": "D.",
                "last": "Groman"
            },
            {
                "email": null,
                "first": "Jacqueline",
                "initial": "J.",
                "last": "Tate"
            },
            {
                "email": null,
                "first": "Clint",
                "initial": "C.",
                "last": "Pecenka"
            }
        ],
        "doi": "10.1016/j.vaccine.2018.12.056",
        "firstpage": "798",
        "issn": "0264410X",
        "keywords": [
            "Cost-effectiveness",
            "DALY",
            "ICER",
            "Mongolia",
            "Rotavirus",
            "Vaccination"
        ],
        "lastpage": "807",
        "openaccess": "Full",
        "pub_year": 2019,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Projected impact, cost-effectiveness, and budget implications of rotavirus vaccination in Mongolia"
    }
}